Frederick “Eric” Arnold, PhD, on Investigating MARK3 Polyadenylation and Microtubule Dynamics in ALS Models
The postdoctoral scholar at University of California – Irvine discussed further questions he is continuing to investigate.
“Motor neurons, in particular, have these really long axons. And so you have to make sure that the cargo is being trafficked over these super long distances, including RNAs. That's an aspect of 3-prime untranslated region (3′-UTR) biology that alternative polyadenylation regulates. [In] some other work that's been done, they refer to it as zip codes. So, within the 3′-UTR, you can havemotifs or sequences that will affect whether an RNA is more localized to thecell body, or is being trafficked along axons to these distal regions.”
Cases of amyotrophic lateral sclerosis (ALS) with known genetic causes also make up around 5-10% of ALS cases. Of these cases, the predominant associated genes are SOD1 and C9orf72. New research from University of California – Irvine is examining the TDP-43 protein, and how changes in alternative polyadenylation that are regulated by TDP-43 affect neuronal cells and ALS.The project is headed by Frederick “Eric” Arnold, PhD, postdoctoral scholar.
Arnold discussed the ongoing research during a session at the
REFERENCES
1. Arnold F. Characterization of Alternative Polyadenylation Events in ALS Highlights New Disease Mechanisms and Novel Gene Therapy Targets. Presented at: 2024 MDA Clinical and Scientific Conference; March 3-6; Orlando, FL.
2. Amyotrophic Lateral Sclerosis (ALS): Causes/Inheritance. MDA website. https://www.mda.org/disease/amyotrophic-lateral-sclerosis/causes-inheritance#:~:text=About%205%2D10%25%20of%20ALS,specific%20region%20of%20a%20chromosome.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025
- Duchenne Action Month 2025: Looking Back at News and Expert Insights
September 14th 2025
- CGTLive®’s Weekly Rewind – September 12, 2025
September 12th 2025